Red Flags Detected

  • Material Weakness (new) — Company identified material weakness in controls over complex transaction accounting that could result in material misstatement.
  • Delisting (worsened) — Active Nasdaq bid price deficiency notice with 180-day cure period ending November 9, 2026; prior period only warned of potential future noncompliance.
  • Going Concern (removed) — Baseline disclosed substantial doubt about going concern with cash runway to early August 2025; current filing omits this language entirely.
NASDAQ: RANI Rani Therapeutics Holdings, Inc. 10-Q

Rani exits going-concern crisis but faces Nasdaq delisting risk; controls deemed ineffective

Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade RANI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.